Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial
- Status
- TERMINATED
- Phase
- PHASE3
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE3
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
- Status
- COMPLETED
- Phase
- PHASE4
INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE4
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
- Status
- COMPLETED
- Phase
- PHASE4
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Rt-PA in the Treatment of Acute Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE3
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type
- Status
- COMPLETED
- Phase
- PHASE2
Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)
- Status
- COMPLETED
- Phase
- PHASE3
The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
- Status
- UNKNOWN
- Phase
- NA
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis
- Status
- COMPLETED
- Phase
- PHASE3
A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)
- Status
- COMPLETED
- Phase
- PHASE2